CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹2.82 Cr | ₹1.96 Cr | ₹2.30 Cr | ₹1.87 Cr | ₹2.10 Cr |
What is the latest Long Term Provisions ratio of CONCORD BIOTECH ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹2.82 Cr |
| Mar2024 | ₹1.96 Cr |
| Mar2023 | ₹2.30 Cr |
| Mar2022 | ₹1.87 Cr |
| Mar2021 | ₹2.10 Cr |
How is Long Term Provisions of CONCORD BIOTECH Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹2.82 Cr | 44.17 | |
| Mar2024 | ₹1.96 Cr | -14.85 | |
| Mar2023 | ₹2.30 Cr | 22.57 | |
| Mar2022 | ₹1.87 Cr | -10.68 | |
| Mar2021 | ₹2.10 Cr | - | |
Compare Long Term Provisions of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹12,500.7 Cr | 13% | 17.6% | -26.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,663.0 Cr | 5.2% | 3.8% | -1.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,692.0 Cr | 2.2% | 11.3% | 7.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹143,909.0 Cr | 0.8% | 0.7% | 25.7% | Stock Analytics | |
| CIPLA | ₹107,827.0 Cr | 1.3% | 9.1% | -15.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,500.0 Cr | -3.5% | 2.7% | 10.3% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | 13% |
17.6% |
-26.5% |
| SENSEX | 0.8% |
5% |
-2.5% |
You may also like the below Video Courses